Catalyst

Slingshot members are tracking this event:

PDUFA date for Dupixent (dupilumab) in Nasal polyps under priority review June 26, 2019

Source Link:
http://hugin.info/152918/R/2237845/881676.pdf

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
SNY Community voting in process
REGN Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jun 26, 2019
Occurred Source:
https://newsroom.regeneron.com/news-releases/news-release-details/fda-approves-dupixentr-dupilumab-chronic-rhinosinusitis-nasal
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Dupixent, Dupilumab, Nasal Polyps
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.